Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Retirees benefit from selecting tax-efficient asset classes and optimized withdrawal sequencing. Learn which classes to favor and why.
23,930 articlesBarclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
When a beloved artist leans into a high-profile relationship, questions rise about independence and money. This guide...
The U.S. economy grew at a 2.0% annualized rate in Q1, powered by AI-related investment and resilient consumer spendi...
Ted Turner's launch of CNN and the dawn of nonstop coverage reshaped investing and budgeting for households. This pie...
MIAX is shaping 2026 in a dynamic way, and the first-quarter earnings transcript offers clues about growth drivers an...
BigBear.AI delivers a stronger Q1 2026, expanding margins and backlog while signaling a ramp in defense contracts. Th...
Palantir’s latest quarter delivered impressive numbers, but the stock asks for more than strong growth. This guide br...
As POST releases its Q2 2026 numbers, investors crave clarity on growth, margins, and guidance. This article breaks d...
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
Costco crossed the $1,000 mark in early May 2026, prompting fresh debate about selling in May—even for blue-chip equi...
Hims & Hers is set to report Q1 earnings after the close as investors weigh a rebound in shares and the pace of cash ...
Plaid’s CFO highlights a surge in internal AI experiments as teams share weekend builds. The push comes as Plaid expa...